Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0689
+0.0039 (6.00%)
May 26, 2026, 3:48 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
272350404523
Market Cap Growth
-32.01%-53.45%25.33%-11.35%96.93%-1.55%
Enterprise Value
302653434823
Last Close Price
0.070.060.120.100.110.06
PS Ratio
475.2669.9081.7972.2145.94-
PB Ratio
-4.06-3.73-8.46-5.30-7.29-5.51
EV/Sales Ratio
-76.9486.0577.2548.64-
Debt / Equity Ratio
-0.41-0.47-0.53-0.40-0.35-0.42
Net Debt / Equity Ratio
-0.38-0.43-0.48-0.39-0.35-0.25
Net Debt / EBITDA Ratio
-0.51-0.56-0.73-1.18-0.76-0.23
Net Debt / FCF Ratio
-0.98-0.82-0.88-1.15-0.71-1.05
Asset Turnover
0.090.400.500.320.36-
Quick Ratio
0.030.040.040.010.000.09
Current Ratio
0.060.080.140.150.230.45
Return on Assets (ROA)
-501.90%-355.41%-200.92%-89.58%-64.62%-141.40%
Return on Capital Employed (ROCE)
74.90%78.10%66.10%33.00%46.60%110.80%
Earnings Yield
-20.43%-23.12%-9.38%-7.70%-7.82%-24.01%
FCF Yield
--14.16%-6.51%-6.39%-6.69%-4.39%
Buyback Yield / Dilution
-0.07%-0.11%-0.07%-0.01%-2.76%-3.81%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.